Monthly Archives: February 2019

Changing Organizational Culture Requires Senior Management To Lead The Way

Who is most accountable for an organization’s culture? Leaders are, or anyone who others look to for guidance, especially people who hold senior positions. The reason is simple, leaders are the single most important factor in determining the success of any culture change effort.

New York, United States – February 25, 2019 /PressCable/

Organizational culture and organizational culture change is not the sole responsibility of the Human Resources department. The chance of successfully establishing a sound company culture depends on the people in senior leadership roles, their behavior, the practices they use and the environment they establish, according to Dr. Nancie Evans’ latest article titled, “Culture Change: Senior Leaders Must Lead The Way”. Leaders must commit time, people and money if the culture change effort has any chance of being successful. Even more important, they must be fully committed to and personally involved in a meaningful way in all phases of the change effort. They are going to have to lead the way which means showing, not just telling others what is expected, making tough decisions and creating the conditions for success.

Dr. Evans comments, “In almost every organization I’ve worked with, Human Resources are responsible for culture. Leaders might say they own it, but the reality is they typically articulate values then hand off the heavy lifting to Human Resources to make the change happen. Unfortunately, this doesn’t work.”

The responsibility for organizational culture and culture change lies with senior management. Other leaders and people who are looked to for guidance are highly influential but they are limited by the conditions established by senior leaders. It is the actions of senior leaders that send clear messages to the rest of the organization as to the expected way of doing things. If their actions are not consistent with their words, there is conflict, confusion and the chance of successful culture change is drastically reduced.

“Leaders need to walk the talk and be aware that their people are very alert to conflicting messages. Leader’s actions send messages to others. Leaders need to reinforce culture in day-to-day practices. Finally, leaders need to create the conditions or environment for success.” adds Dr. Evans.

The article goes into detail about the overall subject of the importance of a leaders involvement in developing a solid culture for the organization. The full article can be found in the blog section of Culture Strategy Fit’s website. https://culturestrategyfit.com/culture-change-senior-leaders-must-lead-the-way/

About Culture-Strategy Fit®

Culture-Strategy Fit® provides Leaders and HR/OD professionals with proven, practical and effective products and services to help them do great culture work in organizations. With over 30 years of experience partnering with organizations from small start-ups and teams to global multi-nationals, they back-up their products with expert guidance and support. This includes turning good cultures into great ones, shifting culture to keep pace with external change and expectations and managing cultural differences to maximize the ROI of mergers and acquisitions. Culture-Strategy Fit’s® dedicated team of culture experts are passionate about sharing their knowledge and expertise, providing value and making a difference, while helping people create high performing cultures and great places to work.This includes understanding cultural differences in mergers and acquisitions.

About Dr. Nancie Evans

Dr. Nancie Evans is a culture and leadership expert who works with executives and their organizations to develop the personal and organizational capability required to deliver new strategies and capitalize on new business models. Her approach is informed by in-depth knowledge of the relationship between leadership behaviors and practices, culture and strategy. Her unique perspective helps our clients implement high impact organizational culture assessments systems, culture change roadmaps and organizational development plans to achieve sustainable change and improved performance.

As a leadership and culture management consultant, Nancie provides organizational consulting to clients around the world in three key areas of expertise:

Enterprise – For executives who must lead their organizations through significant transformation and leverage and strengthen their unique organizational DNA

Leadership Teams – For those who must accelerate execution of organizational strategy, build leadership bench strength and develop cultural capabilities in their groups

Executives – For individual executives working in complex, competitive organizations that need to take themselves and their groups through significant change in new ways

Nancie leads CSF’s Research and Assessment Center and has developed a unique suite of very sensitive, leading-edge diagnostic tools and approaches that provide leaders with deep insights into their behaviors, the culture of their organizations, how this is supporting or hindering strategy execution, as well as the levers they can use to proactively shape culture fit to future goals.

Contact Info:
Name: Dr. Nancie Evans
Email: Send Email
Organization: Culture Strategy Fit Inc.
Address: 3 Columbus Circle 15th Floor 15th Floor , New York, New York 10019, United States
Phone: +1-212-960-8110
Website: https://culturestrategyfit.com

Source: PressCable

Release ID: 485194

Galway Gold Updates Status of Actions Taken to Recover Costs and Damages from the Colombian Government in Respect of the Reina de Oro Project

TORONTO, ON / ACCESSWIRE / February 25, 2019 / Further to its news release dated March 27, 2018, Galway Gold Inc. (TSX-V: GLW) (”Galway Gold” or the ”Company”) announces an update to the status of the Company’s arbitration claim against the Republic of Colombia brought under the Canada-Colombia Free Trade Agreement (”FTA”) to preserve Galway Gold’s rights under the FTA.

On March 21, 2018, Galway Gold filed a Request for Arbitration against the Republic of Colombia before the International Centre for Settlement of Investment Disputes (”ICSID”). The Request for Arbitration contends that Colombia breached its obligations under the FTA in failing to compensate Galway for the losses incurred as a consequence of Colombia’s prohibition of mining in the páramos (high altitude eco-systems). The Request for Arbitration seeks, among other relief, recovery of the Company’s costs incurred in the acquisition and development of its investment in the Reina de Oro mining project, as well as the loss of value suffered.

The Company was represented by Ignacio Suarez Anzorena of Clifford Chance US LLP, for the initial phase of the arbitration, including filing the Request for Arbitration required under applicable ICSID procedures. As the arbitration moves to the next phase, the Company has appointed litigator Lawrence Thacker, Senior Partner of Lenczner Slaght LLP, as its new lead counsel in this matter.

The Arbitral Tribunal will consist of three Arbitrators. Two Arbitrators have been appointed. The Company has now taken steps for the appointment of the third Arbitrator who will serve as President of the Tribunal. The Company intends to continue to vigorously seek to preserve its rights under the FTA and obtain full compensation for all losses incurred.

For further information contact:

Galway Gold Inc.

Robert Hinchcliffe
1-800-761-2770
www.galwaygoldinc.com

Cautionary Note Regarding Forward-Looking Statements:

This News Release includes certain “forward-looking statements” which are not comprised of historical facts. Forward-looking statements include estimates and statements that describe Galway Gold’s future plans, objectives or goals, including words to the effect that Galway Gold or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as ”believes”, ”anticipates”, ”expects”, ”estimates”, ”may”, ”could”, ”would”, ”will”, or ”plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to Galway Gold, Galway Gold provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward looking information in this news release includes, but is not limited to, statements related to the termination of the Reina de Oro project, the ability to recover damages with respect to the termination of the Reina de Oro project in any amount or not at all, Galway Gold’s objectives, goals or future strategic plans and new corporate opportunities, and the Company’s ability to find a viable resource project in Colombia or an alternative mining jurisdiction. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to an inability to recover damages in respect of the termination of the Reina de Oro project, failure to identify a viable resource project, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects, capital and operating costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry, and those risks set out in Galway Gold’s public documents filed on SEDAR. Although Galway Gold has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in the forward-looking information, there may be other factors that cause actions, events, or results not to be as anticipated, estimated, or intended. There can be no assurance that forward-looking information will prove to be accurate. The forward-looking information contained herein is presented for the purposes of assisting investors in understanding Galway Gold’s plans, objectives, and goals and may not be appropriate for other purposes. Accordingly, readers should not place undue reliance on forward-looking information. Galway Gold does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Galway Gold Inc.

ReleaseID: 536456

Theralase Announces Appointment of New Chief Executive Officers

TORONTO, ON / ACCESSWIRE / February 25, 2019 / Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations intended to safely and effectively destroy various cancers is pleased to announce the appointment of Shawn Shirazi, Ph.D., to the role of CEO of Theralase’s Drug Division (“CEO-Drug”) and Kipton Lade, B.Sc., M.Sc., MBA., to the role of Chief Executive Officer (“CEO”) of Theralase’s Device Division (“CEO-Device”).

Shawn Shirazi, Ph.D. Pharmacology obtained his B.Sc. in Chemistry from York University (Toronto, Ontario, Canada) and a M.Sc. and Ph.D. in Pharmacology from the University of Ottawa (Ottawa, Ontario, Canada).

Dr. Shirazi brings over 20 years of hands-on experience in: pharmaceutical drug formulation and development, clinical trial management, Good Manufacturing Practices (“GMP”) international drug manufacture, international regulatory guidelines and quality assurance in GMP drug manufacture. He has held senior roles with both start-ups and large pharmaceutical organizations, including: Executive Director and Vice President of Research and Development for Torpharm Inc (Division of Apotex (Apotex worldwide revenue $CAN 1.19 B (2016)), Senior Director Global Research and Development of Perrigo Company (NYSE: PRGO, $US 6.7 B Market Cap) and Chief Operating Officer – North America for Daxinganling Lingonberry Boreal Biotech Co. Ltd. (Leading manufacturer of high quality plant extracts, based in China), During his career, Dr. Shirazi has led the generic drug development programs for numerous pharmaceutical organizations, resulting in multiple “First To File” (“FTF”) drug applications, allowing product exclusivity, as well as global leadership of research and development and merger and acquisition portfolios.

Dr. Shirazi, CEO – Drug, Theralase stated, “I am delighted to join the Theralase family with a mandate of developing and commercializing a truly amazing life saving technology. My expertise has been in directing high performance teams in formulating complex medicinal products and drugs, design of bioavailability & bioequivalence studies and regulatory submission tactics that resulted in over US$450 million revenue generated from FTF patent applications leading to market exclusivity. Furthermore, I have structured and led teams responsible for GMP drug manufacture through analytical technology transfer, collaborating in drug and clinical development planning and execution, negotiating with regulatory authorities and obtaining regulatory approvals that resulted in successful product launches on time and on budget.”

Mr. Lade earned his B.Sc. in Biomedical Engineering and M.Sc. in Electrical Engineering from Marquette University (Milwaukee, Wisconsin, USA) and his MBA from the University of St. Thomas (St. Paul, Minnesota, USA).

Mr. Lade, has over 25 years of global experience developing and launching new medical technologies and therapies, through the execution of objective corporate strategies. In his last appointment, Mr. Lade served as the President and CEO at Thornhill Medical (Toronto, Ontario, Canada). At Thornhill Medical, he successfully completed a business turn around, which included: launch of global distribution, new product introductions, multi-million dollar US Department of Defense tender award and the completion of a Series A financing. Prior to Thornhill Medical, Mr. Lade served in various senior management positions, such as Director of Sales and Marketing at Boston Scientific (Toronto, Ontario, Canada), General Manager of Alvimedica – Canada (Toronto, Ontario, Canada), Managing Director at Biotronik (Berlin, Germany), General Manager of St. Jude Medical – Canada (Toronto, Ontario, Canada) and Director of Global Product Marketing for St. Jude Medical (Saint Paul, Minnesota, USA). As a senior executive and expert in sales and marketing, he has led his direct report teams to significantly increase their share of global revenue, through the global launch of highly innovative medical systems and new technology platforms.

Mr. Lade, CEO – Device, Theralase stated, “I am pleased to join the Theralase team, in the capacity of CEO of their Device Division and I look forward to leading this division to break-even status and then profitability through the systematic development and successful execution of a global corporate strategy.

This strategy includes:

Global launch of Theralase’s therapeutic cold laser technology, which I believe offers tremendous opportunity for value creation.
Global launch of Theralase’s anti-cancer laser technology, which when used in combination with Theralase’s patented PDCs offers a formidable arsenal in the war on cancer
Global launch of new technologies aimed at treating some of the major medical conditions still prevalent in the world today

I have a personal passion for the ground-breaking therapies, that Theralase is introducing to the medical community and I believe that my diverse global experience in: launching new products, increasing corporate revenue and building dynamic teams that deliver results, is a perfect match for Theralase. I believe we have the winning formula to launch Theralase technology to the next level and join the ranks as a recognized global leader in the fields of healing pain and destroying cancer.”

Guy Anderson, BA, CFP, CIM, FMA, FCSI, MBA, Director and Chairman of the Board, Theralase stated, “On behalf of the Board, I am delighted that Kipton and Shawn have elected to join our team to help fulfil our corporate mandate of globally commercializing the Theralase medical laser technology for both therapeutic and oncological applications. I look forward to working with both of them as they utilize their immense expertise and proven track record to execute on Theralase’s strategic objectives. Our primary corporate strategic objective is the commercialization of our TLD-1433 anti-cancer technology through the successful completion of a Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC”) clinical study, slated to commence in 2019.”

About Theralase® Technologies Inc.

Theralase® is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers.

Additional information is available at www.theralase.com and www.sedar.com

This news release contains “forward-looking statements” which reflect the current expectations of management of the Company’s future growth, results of operations, performance and business prospects and opportunities. Such statements include, but are not limited to, statements regarding the Company’s proposed development plans with respect to Photo Dynamic Compounds and their drug formulations. Wherever possible, words such as “may”, “would”, “could”, “should”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions have been used to identify these forward-looking statements. These statements reflect management’s current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions including with respect to the ability of the Company to: successfully fund and complete a Phase II NMIBC clinical study, secure the requisite regulatory approvals to commence a Phase II NMIBC clinical study and implement its development plans. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements; including, without limitation, those listed in the filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the press release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. The Company disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

For More Information:

1.866.THE.LASE (843-5273)
416.699.LASE (5273)
info@theralase.com
www.theralase.com

SOURCE: Theralase Technologies Inc.

ReleaseID: 536460

Completion of Private Placement and Holdings in the Company

LONDON, UK / ACCESSWIRE / February 25, 2019 / Further to the announcement by the Company on 1 February 2019 regarding the placement of 7,291,667 new Ordinary Shares (the “Placement”) and 3,645,831 warrants in the Company and including a first tranche of the Placement for 4,166,667 new, Ordinary Shares (the “Initial Placement”), Condor Gold (AIM: CNR; TSX: COG) announces the following:

The Company confirms that £750,000 has been remitted to the Company in connection with the second and final tranche of the Placement, comprising a subscription (the “MellonSubscription”) for 3,125,000 new Ordinary Shares (the “Mellon Shares”) by Jim Mellon, a non-Executive Director of the Company. The Placement has therefore now closed. Each new Ordinary Share issued as part of the Placement shall have attached to it one half of a warrant with an exercise price of 31p per warrant and a validity of 2 years from issue.

The new Ordinary Shares issued in respect to the Initial Placement were admitted to trading on 8 February 2019. Admission to trading of the Mellon shares is anticipated to occur on or around 26 February 2019.

Following the Placement the Company’s issued share capital is now 74,471,002 Ordinary shares.

The above figure of 74,471,002 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change in interest in, the share capital of the Company under the Financial Conduct Authority’s Disclosure and Transparency Rules.

To the knowledge of the Company, those shareholders individually holding in excess of 3.0 percent of the Company’s issued share capital are as follows:

Shareholder

Shares Held

Percentage of total issued shares

Jim Mellon *

7,828,105

10.5%

Ross Beaty

5,316,903

7.1%

Mark Child *

4,094,167

5.5%

Oracle Investments Ltd

4,077,038

5.5%

City Financial Investment Company Ltd

3,486,376

4.7%

International Finance Corporation

3,425,000

4.6%

* Director of the Company

Jim Mellon now owns a direct and indirect aggregate shareholding of 7,828,105 Ordinary shares, or 10.5% of the Company. The direct interest is in 2,889,883 Ordinary Shares and the indirect interest is in 4,938,222 Ordinary Shares held through Galloway Limited. Galloway Limited is wholly owned by Burnbrae Group Limited, which in turn is wholly owned by Jim Mellon.

As at today’s date and including those warrants issued as part of the placement of Ordinary shares as announced today by the Company, issued warrants in the Company are as follows:

Number of warrants

Expiry date

Exercise Price £

Amount raised if fully issued £

4,227,364

28 February 2019

£0.93

£ 3,931,449

2,906,975

28 March 2020

£0.65

£ 1,889,534

2,083,331

8 February 2021

£0.31

£ 645,832

1,562,500

22 February 2021

£0.31

£ 484,375

For further information please visit www.condorgold.com or contact:

Condor Gold plc

Mark Child, Chairman and CEO
+44 (0) 20 7493 2784

Beaumont Cornish Limited

Roland Cornish and James Biddle
+44 (0) 20 7628 3396

Numis Securities Limited

John Prior and James Black
+44 (0) 20 7260 1000

Blytheweigh

Tim Blythe, Camilla Horsfall and Megan Ray
+44 (0) 20 7138 3204

Condor Gold plc was admitted to AIM in May 2006 and dual listed on the TSX in January 2018. The Company is a gold exploration and development company with a focus on Nicaragua.

In August 2018, the Company announced that the Ministry of the Environment in Nicaragua had granted the Company the Environmental Permit (“EP”) for the development, construction and operation of a processing plant with capacity to process up to 2,800 tonnes per day at its wholly-owned La India gold project (“La India Project”). The EP is considered to be the master permit for mining operations in Nicaragua. Condor Gold published a Pre-Feasibility Study (“PFS”) on La India Project in December 2014, as summarised in the Technical Report entitled “Technical Report on the La India Gold Project, Nicaragua, December 2014”, dated November 13, 2017 with an effective date of December 21, 2014 (the “Technical Report”), prepared in accordance with NI 43-101. The Technical Report was prepared by or under the supervision of Tim Lucks, Principal Consultant (Geology & Project Management), Gabor Bacsfalusi, Principal Consultant (Mining), Benjamin Parsons, Principal Consultant (Resource Geology), each of SRK Consulting (UK) Limited, and Neil Lincoln of Lycopodium Minerals Canada Ltd., each of whom is an independent “qualified person” as defined by NI 43-101. The PFS details an open pit gold Mineral Reserve in the Probable category of 6.9 Mt at 3.0 g/t gold for 675,000 oz gold, producing 80,000 oz gold per annum for seven years. La India Project contains a Mineral Resource (“Mineral Resource Estimate”) in the Indicated category of 9,850Kt at 3.6 g/t gold for 1,140Koz gold and 8,479Kt at 4.3g/t gold for 1,179Koz gold in the Inferred category. The Indicated Mineral Resource is inclusive of the Mineral Reserve. The Mineral Resource Estimate is dated January 25, 2019 and was prepared by SRK Consulting (UK) Limited (“SRK”) using the terminology, definitions and guidelines given in the Canadian Institute of Mining, Metallurgy and Petroleum (CIM) Standards on Mineral Resources and Mineral Reserves (May 2014).

The technical and scientific information in this press release has been reviewed, verified and approved by Andrew Cheatle, P.Geo., who is a “qualified person” as defined by NI 43-101.

Disclaimer

Neither the contents of the Company’s website nor the contents of any website accessible from hyperlinks on the Company’s website (or any other website) is incorporated into, or forms part of, this announcement.

Forward Looking Statements

All statements in this press release, other than statements of historical fact, are ‘forward-looking information’ with respect to the Company within the meaning of applicable securities laws, including statements with respect to: the capital structure and exercising of warrants, the Mineral Resources, Mineral Reserves and future production rates and plans at the La India Project. Forward-looking information is often, but not always, identified by the use of words such as: “seek”, “anticipate”, “plan”, “continue”, “strategies”, “estimate”, “expect”, “project”, “predict”, “potential”, “targeting”, “intends”, “believe”, “potential”, “could”, “might”, “will” and similar expressions. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management at the date the statements are made including, among others, assumptions regarding: future commodity prices and royalty regimes; availability of skilled labour; timing and amount of capital expenditures; future currency exchange and interest rates; the impact of increasing competition; general conditions in economic and financial markets; availability of drilling and related equipment; effects of regulation by governmental agencies; the receipt of required permits; royalty rates; future tax rates; future operating costs; availability of future sources of funding; ability to obtain financing and assumptions underlying estimates related to adjusted funds from operations. Many assumptions are based on factors and events that are not within the control of the Company and there is no assurance they will prove to be correct.

Such forward-looking information involves known and unknown risks, which may cause the actual results to be materially different from any future results expressed or implied by such forward-looking information, including, risks related to: mineral exploration, development and operating risks; estimation of mineralisation, resources and reserves; environmental, health and safety regulations of the resource industry; competitive conditions; operational risks; liquidity and financing risks; funding risk; exploration costs; uninsurable risks; conflicts of interest; risks of operating in Nicaragua; government policy changes; ownership risks; permitting and licencing risks; artisanal miners and community relations; difficulty in enforcement of judgments; market conditions; stress in the global economy; current global financial condition; exchange rate and currency risks; commodity prices; reliance on key personnel; dilution risk; payment of dividends; as well as those factors discussed under the heading “Risk Factors” in the Company’s annual information form for the fiscal year ended December 31, 2017 dated March 29, 2018, available under the Company’s SEDAR profile at www.sedar.com.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Condor Gold PLC

ReleaseID: 536587

National Energy Services Reunited Corp. Reports Fourth Quarter and Full Year 2018 Financial Results

HOUSTON, TX / ACCESSWIRE / February 25, 2019 / National Energy Services Reunited Corp. (“NESR” or the “Company”) (NASDAQ: NESR) (NASDAQ: NESRW), a national, industry-leading provider of integrated energy services in the Middle East and North Africa (“MENA”) and Asia Pacific regions, today reported results for the quarter and year ended December 31, 2018.

Operating and Financial Highlights

Revenue for the combined NESR companies for 2018 was $553 million, growing over 20% as compared to the prior-year performance of the legacy companies. Post-combination revenue for the second half of 2018 grew 22% from the first half of the year and 27% compared to the prior-year period.
Quarterly revenue grew by 30% compared to the prior-year quarter and sequentially by 9%. Quarter-over-quarter growth was driven by higher activity levels across segments despite commodity pricing weakness experienced during the fourth quarter.
Net income for the fourth quarter was $23 million compared to $16 million for the preceding period and $40 million for combined NESR companies for full year 2018. Net income generated after the Business Combination from June 7 to December 31, 2018 was $35 million. Excluding transaction and integration costs, the net income for 2018 was $66 million and the Company delivered a basic earnings of approximately 77 cents per share in 2018 on a pre-transaction and integration cost basis.

Adjusted EBITDA for the combined NESR companies for 2018 was $162 million, producing year-over-year growth of nearly 10%. Post-combination Adjusted EBITDA for the second half of 2018 was $96 million, up approximately 48% sequentially and more than 13% compared to the prior-year period.
Adjusted EBITDA for the fourth quarter was $50 million, up nearly 7% sequentially and approximately 14% compared to the prior-year quarter.
Drilling and Evaluation Services segment produced both top and bottom-line growth in excess of 50% during the quarter compared to the prior-year quarter and over 25% growth in full-year 2018 compared to the prior year. Production Services segment produced 11% revenue growth quarter-over-quarter and 13% revenue growth year-over-year.
Solid cash generation from ongoing operations with the Company repaying $44 million in December 2018 for the principal and interest on the $50 million convertible loan taken to fund the business combination in June 2018 and the balance fully repaid in January 2019.

Sherif Foda, Chairman of the Board and CEO of NESR said, “2018 was a transformative and pivotal year for NESR. We have progressed from an idea and ambition to the largest national oilfield services company in the region. I strongly believe our performance in the two quarters since closing gives a preview of what is to be expected of NESR in the future. I am incredibly proud of our employees and the commitment they have shown to our philosophy of putting customers first.”

Mr. Foda continued, “As demonstrated by the recent announcements of our customers, we believe regional E&P spend will significantly increase in the coming five years. In turn, this spending will drive strong growth in the overall services market. The healthy macro environment, coupled with our exceptional service delivery platform, our growth investments and our recognized position as the national oilfield services champion, puts us in a very good position for 2019 and beyond.”

Net Income Results

The Company had net income for the fourth quarter totaling $22.8 million, which includes the impact of $1.2 million of transaction and integration costs related to the Business Combination completed in June 2018 and $4.1 million of purchase accounting related amortization costs incurred in the fourth quarter. Additionally, the Company had a non-recurring adjustment to net income recorded for an acquisition-related earn-out at year end totaling $6.1 million in the fourth quarter.

The Company is reporting incomes taxes during the successor period from June 7, 2018 through December 31, 2018 of $9.4 million. The successor period effective tax rate for 2018 was 21.2%, effected by certain non-deductible transaction costs in 2018. Additional restructurings will enable further tax efficiencies beginning in 2019.

See “Business Combination Accounting and Presentation of Results of Operations” section below for additional information on current reporting conventions.

Combined Company Results

On a combined basis, the Company produced net income of $39.5 million for the year ended December 31, 2018 and produced Adjusted EBITDA of $161.7 million over that same period. Both net income and EBITDA included adjustments for transaction and integration costs of $26.2 million and the aforementioned earn-out adjustment. The NESR companies collectively posted the following results during 2018 on a combined basis for the periods presented.

(in
thousands)

October 1 to December 31, 2018

June 30 to September 30, 2018

April 1 to June 30, 2018

January 1 to March 31, 2018

Revenue

$
158,024

$
145,580

$
131,355

$
117,560

Net
Income

$
22,788

$
16,157

$
(5,465
)

$
6,044

Adjusted EBITDA

$
49,948

$
46,473

$
34,257

$
31,068

Production Services Segment Results

Production Services contributed $98.1 million to consolidated revenue for the fourth quarter period as compared to $88.7 million of revenue during the prior quarter. Segment EBITDA totaled $35.1 million in the fourth quarter as compared to $33.2 million in the prior quarter. This segment benefitted from higher coil tubing and stimulation activities in Saudi Arabia, Qatar, Iraq, and the United Arab Emirates during the fourth quarter. The Production Services segment posted the following results for the periods presented.

Successor (NESR)

Predecessor (NPS)

(in
thousands)

June 7 to

December 31, 2018

January 1 to June 6, 2018

January 1 to December 31, 2017

January 1 to December 31, 2016

Revenue

$
215,791

$
112,295

$
228,763

$
190,990

EBITDA

$
77,482

$
36,836

$
81,780

$
72,138

Drilling and Evaluation Services Segment Results

Drilling and Evaluation (“D&E”) Services contributed $61.1 million to consolidated revenue for the fourth quarter period as compared to revenue of $56.9 million in the prior quarter. Segment EBITDA totaled $14.4 million in the fourth quarter down from $17.6 million in the prior quarter. Prior quarter segment EBITDA included a non-recurring gain on the sale of a drilling business and a product line mix which yielded stronger overall margins. Additionally, the D&E Services segment experienced higher rental costs due to increased activity in the fourth quarter.

Our D&E Services segment has produced top line growth throughout the year and has demonstrated year-over-year growth on the top and bottom lines of greater than 25%. New contracts for well testing and logging activity in Saudi Arabia and Iraq have contributed to this strong performance. The D&E Services segment posted the following results for the periods presented.

Successor (NESR)

Predecessor (NPS)

(in
thousands)

June 7 to

December 31, 2018

January 1, 2018 to June 6, 2018

January 1 to December 31, 2017

January 1 to December 31, 2016

Revenue

$
132,799

$
24,732

$
42,561

$
33,125

EBITDA

$
32,782

$
3,267

$
4,952

$
7,245

Offsetting both our Production and D&E Services segment results were certain Corporate costs which are not yet allocated to segment operations.

Balance Sheet

Cash and cash equivalents were $24.9 million as of December 31, 2018 (Successor), compared to $24.5 million as of December 31, 2017 (Predecessor) and $67.6 million as of September 30, 2018.

The Company had a convertible loan maturing during December 2018 (the Hana Loan). During 2018, the Company paid $44 million for both principal and interest in cash and entered into an extension for the balance of the loan which was fully repaid with cash in January 2019. Total debt as of December 31, 2018 was $302.1 million with $76.9 million of such debt classified as short-term.

Predecessor/Successor Accounting Treatment

NESR continues to report in a Predecessor/Successor format whereby NPS is the Predecessor for periods prior to the completion of the Business Combination on June 7, 2018 and NESR, including NPS and GES, is the Successor for post-transaction periods.

Conference Call Information

NESR will host a conference call on Monday, February 25, 2019, to discuss the fourth quarter and full year 2018 financial results. The call will begin at 9:00 AM Eastern Time.

Investors, analysts and members of the media interested in listening to the call are encouraged to participate by dialing into the toll-free line at 1-877-407-0312 or the international line at 1-201-389-0899. A live, listen-only webcast will also be available in the investors section of www.nesr.com. A replay of the conference call will be available a few hours after the event in the investors section of the Company’s website.

About National Energy Services Reunited Corp.

Founded in 2017, NESR is one of the largest national oilfield services providers in the MENA and Asia Pacific regions. With over 3,500 employees, representing more than 40 nationalities in over 15 countries, the Company helps its customers unlock the full potential of their reservoirs by providing Production Services such as Cementing, Coiled Tubing, Filtration, Completions, Stimulation and Fracturing, and Nitrogen Services. The Company also helps its customers to access the reservoirs in a smarter and faster manner by providing Drilling and Evaluation Services like Drilling Downhole Tools, Directional Drilling Fishing Tools, Testing Services, Wireline, Slickline, Fluids and Rig Services.

Business Combination Accounting and Presentation of Results of Operations

As a result of the Business Combination, NESR was determined to be the accounting acquirer and NPS was determined to be the predecessor for SEC reporting purposes. Pursuant to Accounting Standard Codification (“ASC”) 805, Business Combinations (“ASC 805”), a preliminary assessment was made as of the acquisition-date fair value of the purchase consideration paid by NESR to effect the Business Combination was allocated to the assets acquired and the liabilities assumed based on their estimated fair values. As a result of the application of the acquisition method of accounting resulting from the Business Combination, the financial statements and certain footnote presentations separate our presentations into two distinct sets of reporting periods, the periods before the consummation of the transaction (“Predecessor Periods”) and the period after that date (“Successor Period”), to indicate the application of the different basis of accounting between the periods presented. The Predecessor Periods reflect the historical financial information of NPS prior to the Business Combination, while the Successor Period reflects our consolidated financial information, including the results of NPS and GES, after the Business Combination. The Successor Periods are from June 7, 2018 to December 31, 2018 and for the three months ended December 31, 2018. The Predecessor Periods are from January 1, 2017 to December 31, 2017, for the three months ended December 31, 2017 and from January 1, 2018 to June 6, 2018.

Forward-Looking Statements

This communication includes certain statements that may constitute “forward-looking statements” for purposes of the federal U.S. securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, the future financial performance of NESR; and changes in NESR’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management. These forward-looking statements are based on information available as of the date of this communication, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing NESR’s views as of any subsequent date, and NESR does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You should not place undue reliance on these forward-looking statements. As a result of a number of known and unknown risks and uncertainties, NESR’s actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include NESR’s ability to execute its strategy, which may be affected by, among other things, competition and the ability of NESR to grow and manage growth profitably; changes in applicable laws or regulations; the possibility that NESR may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties indicated in NESR’s public filings with the Securities and Exchange Commission.

The preliminary financial results for the Company’s fourth quarter and year ended December 31, 2018 included in this press release represent the most current information available to management. The Company’s actual results when disclosed in its Annual Report on Form 20-F for the year ended December 31, 2018 may differ from these preliminary results as a result of the completion of the Company’s financial statement closing procedures, final adjustments, completion of the independent registered public accounting firm’s review and audit procedures, and other developments that may arise between now and the disclosure of the final results and audited financials.

NATIONAL ENERGY SERVICES REUNITED CORP. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(Unaudited)
(In thousands, except share data)

Period from June 7 to December 31, 2018

Period from January 1 to June 6, 2018

Period from January 1 to December 31, 2017

Period from January 1 to December 31, 2016

Description

Successor (NESR)

Predecessor (NPS)

Revenues

$
348,590

$
137,027

$
271,324

$
224,115

Cost
of products and services

(249,159
)

(104,242
)

(200,149
)

(157,382
)

Gross profit

99,431

32,785

71,175

66,733

Selling, general and

administrative expense

(36,705
)

(19,969
)

(30,336
)

(25,954
)

Amortization

(9,373
)

(10
)

(607
)

(22,663
)

Operating income

53,353

12,806

40,232

18,116

Interest expense, net

(14,383
)

(4,090
)

(6,720
)

(5,677
)

Other
income (expense), net

5,441

362

(573
)

(1,441
)

Income before income taxes

44,411

9,078

32,939

10,998

Income taxes

(9,431
)

(2,342
)

(4,586
)

(2,648
)

Net income

34,980

6,736

28,353

8,350

Net
income (loss) attributable

to
non-controlling interests

(163
)

(881
)

(2,273
)

(193
)

Net income attributable to shareholders

$
35,143

$
7,617

$
30,626

$
8,543

Weighted average shares outstanding:

Basic

85,569,020

348,524,566

342,250,000

340,932,192

Diluted

86,862,983

370,000,000

370,000,000

368,682,192

Net earnings per share:

Basic

$
0.41

$
0.02

$
0.09

$
0.03

Diluted

$
0.40

$
0.02

$
0.08

$
0.02

The accompanying
notes are an integral part of the unaudited condensed consolidated financial
statements.

NATIONAL ENERGY SERVICES REUNITED CORP. AND SUBSIDIARIES
RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME
(Unaudited)
(In thousands)

The Company uses and presents certain key non-GAAP financial measures to evaluate its business and trends, measure performance, prepare financial projections and make strategic decisions. Included in this release are discussions of earnings before interest, income tax and depreciation and amortization adjusted for certain non-recurring and non-core expenses (“Adjusted EBITDA”), as well a reconciliation of this non-GAAP measure to net income in accordance with U.S. GAAP.

The Company believes that the presentation of Adjusted EBITDA provides useful information to investors in assessing its financial performance and results of operations as the Company’s board of directors, management and investors use Adjusted EBITDA to compare the Company’s operating performance on a consistent basis across periods by removing the effects of changes in capital structure (such as varying levels of interest expense), asset base (such as depreciation and amortization and impairment), items that do not impact the ongoing operations (Business Combination transaction expenses and related integration costs) and items outside the control of its management team. Adjusted EBITDA should not be considered as an alternative to net income, the most directly comparable GAAP financial measure. Non-GAAP financial measures have important limitations as analytical tools because they exclude some but not all items that affect the most directly comparable GAAP financial measure. You should not consider non-GAAP measures in isolation or as a substitute for an analysis of the Company’s results as reported under U.S. GAAP.

Successor (NESR)

Predecessor (NPS), NESR and GES

Successor and Predecessor Combined

June 7 to December 31, 2018

January 1 to June 6, 2018

January 1 to December 31, 2018

Net
Income (loss)

34,980

4,544

39,524

Add:

Income Taxes

9,431

3,705

13,136

Interest Expense, net

14,383

5,096

19,479

Depreciation and Amortization

43,457

26,075

69,532

Transaction and Integration Costs

10,955

15,237

26,192

Earn-out Adjustment

(6,117)

(6,117)

Total
Adjusted EBITDA

107,089

54,657

161,746

Successor (NESR)

September 30 to December 31, 2018

Net
Income (loss)

22,788

Add:

Income Taxes

6,471

Interest Expense, net

6,284

Depreciation and Amortization

19,303

Transaction and Integration Costs

1,219

Earn-out Adjustment

(6,117)

Total
Adjusted EBITDA

49,948

Successor (NESR)

June 30 to September 30, 2018

Net
Income (loss)

16,157

Add:

Income Taxes

3,989

Interest Expense, net

6,199

Depreciation and Amortization

17,694

Transaction and Integration Costs

2,434

Total
Adjusted EBITDA

46,473

Successor (NESR)

Predecessor (NPS), NESR and GES

Successor and Predecessor Combined

June 7 to June 30, 2018

April 1 to June 6, 2018

April 1 to June 30, 2018

Net
Income (loss)

(3,965)

(1,500)

(5,465)

Add:

Income Taxes

(1,029)

1,804

775

Interest Expense, net

1,900

1,370

3,270

Depreciation and Amortization

6,460

10,338

16,798

Transaction and Integration Costs

7,302

11,577

18,879

Total
Adjusted EBITDA

10,668

23,589

34,257

Predecessor (NPS), NESR and GES January 1 To March 31,
2018

Net
Income (loss)

6,044

Add:

Income Taxes

1,901

Interest Expense, net

3,726

Depreciation and Amortization

15,737

Transaction and Integration Costs

3,660

Total
Adjusted EBITDA

31,068

For inquiries regarding NESR, please contact:

Dhiraj Dudeja
NESR Corp.
832-925-3777
info@nesr.com
or
Josh Littman or Steve Calk
Alpha
IR Group
312-445-2870
NESR@alpha-ir.com

SOURCE: National Energy Services Reunited Corp.

ReleaseID: 536690

Spinal Muscular Atrophy Market (2019 Edition): Global Size, Trends, Growth Analysis and 2026 Forecast Research Report Now Available at MarketReportsOnline

MarketReportsOnline.com adds Global Spinal Muscular Atrophy Market: Industry Analysis & Outlook (2019-2026) research report of 72 pages published in February 2019 to the Pharmaceuticals market data collection of its online business intelligence library.

Pune, India – February 25, 2019 /MarketersMedia/

Spinal Muscular Atrophy (SMA) is a form of neuromuscular disease that results in loss of lower motor neurons and progressive muscle wasting, often leading to early death. Presently, it affects about 1 in 11,000 babies and about 1 in every 50 Americans is the disease carrier. On the basis of either the onset age of symptoms, SMA is classified into Type I, Type II, Type III and Type IV diseases.

Complete report on “Global Spinal Muscular Atrophy Market” with providing 4 company profiles, 5 tables and 37 figures is now available at http://www.marketreportsonline.com/782640.html.

Currently, no specific therapies for cure exist, but certain speciality drugs are expected to enter the market in the year 2019. The clinical care differs with the severity or type of the disorder category.

The global market is expected to witness a lucrative growth due the rising pharmaceuticals research and development (R&D) expenditures, increasing personal healthcare expenditure, accelerating economic growth and growing spinal muscular atrophy occurrence. The market is trending with progressing drug pipeline and high preference for gene therapy. However, there are some growth hindering factors in the market including lethargic drug approval process and associated business risks.

Regionally, the U.S. is expected to hold the leading position in the market, due to the increasing prevalence of motor neuron disorders in the population along with high preference of genetic correction therapy and myostatin drugs.

Purchase a copy of this “Global Spinal Muscular Atrophy Market” report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=782640.

“Global Spinal Muscular Atrophy Market: Industry Analysis & Outlook (2019-2026)” provides an extensive research and detailed analysis of the present market along with future outlook. Key players i.e. Biogen Inc., Novartis International AG, Roche Holding AG and Cytokinetics, Inc are being profiled along with their respective financials and growth strategies.

Major Points from Table of Contents:

1. Market Overview
1.1 Introduction
1.2 Classification
1.3 Causes & Symptoms
1.4 Diagnosis
1.5 Treatment

2. Global Spinal Muscular Atrophy Market
2.1 Global Spinal Muscular Atrophy Market Value Forecast
2.2 Global AVXS-101 Gene Therapy Value Forecast
2.3 Global AVXS-101 Gene Therapy Value Forecast by Region
2.4 Global SRK-015 Drug Value Forecast
2.5 Global SRK-015 Drug Value Forecast by Region
2.6 Global Spinal Muscular Atrophy Incidence by Region
2.7 Global Spinal Muscular Atrophy Prevalence by Region

3. Regional Spinal Muscular Atrophy Market
3.1 The U.S. AVXS-101 Gene Therapy Value Forecast
3.2 The U.S. AVXS-101 Gene Therapy Value Forecast by Disease Type
3.3 The U.S. SRK-015 Drug Value Forecast
3.4 The U.S. SRK-015 Drug Value Forecast by Disease Type
3.5 EU AVXS-101 Gene Therapy Value Forecast
3.6 EU AVXS-101 Gene Therapy Value Forecast by Disease Type
3.7 EU SRK-015 Drug Value Forecast
3.8 EU SRK-015 Drug Value Forecast by Disease Type

4. Market Dynamics
4.1 Growth Drivers
4.2 Key Trends and Developments
4.3 Challenges

5. Competitive Landscape
5.1 Global Spinal Muscular Atrophy Market

6. Company Profiles

Explore more Pharmaceuticals Market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html.

About Us:
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: MarketReportsOnline
Phone: + 1 888 391 5441
Website: http://www.marketreportsonline.com/contacts/purchase.php?name=782640

Source URL: https://marketersmedia.com/spinal-muscular-atrophy-market-2019-edition-global-size-trends-growth-analysis-and-2026-forecast-research-report-now-available-at-marketreportsonline/485526

Source: MarketersMedia

Release ID: 485526

Halifax, Dartmouth kitchen Refacing and Quartz Countertop Review

Kitchen Refacers releases its unbiased review of Halifax,Dartmouth Kitchen Refacing and Quartz Counter Tops information can be found at https://www.kitchenrefacers.ca/cabinet-refacing-halifax

Middle Sackville, Canada – February 25, 2019 /PressCable/

Amidst a Mass of online reviews, Kitchen Renovations Website Kitchen Refacers has published its own review of kitchen cabinet refacing in Halifax and Dartmouth, which it claims “finally doesn’t suck”. This statement is made to support the movement for greater quality content online.

Kitchen Refacers makes this statement to oppose the Upsetting over-abundance of excellent review sites, which seemingly publish ‘propaganda’ in order to make affiliate sales.

Robert Stack, Owner at Kitchen Refacers says “We know reviews are absolutely vital to the buying process. That’s why we believe reviews should be genuine and thorough. Otherwise they are taking a risk with someone who can only offer a low quality service and price without a written guarantee or contract”

It appears to Kitchen Refacers that there is a seemingly endless supply of overly positive reviews for many products. Robert Stack believes this is due to business owner who know they can score a positive review if they simply ask . This has the drawback of lowering the integrity of online reviews.

Robert Stack goes on to say “If a product is genuinely excellent, then a website should absolutely give credit where credit is due… but if it’s isn’t so great, then the site should pay equal attention to the less desirable aspects of the product. Otherwise, it just sucks.”

In their online review of kitchen cabinet refacing, Kitchen Refacers makes a point of highlighting the positives. For example, The finished product is enjoyed for many years making your kitchen an enjoyable place to be in.. Also, Once they start using their new kitchen they always ask why did they wait so long .

However, it doesn’t betray its integrity and avoids bias by highlighting the flaws of the kitchen refacing industry too. Such as; Some people over look the kitchen refacing service from information gathered from competition who only offers new kitchen cabinets . Another criticism is the service only offers a limited warranty which cabinet door manufactures offer the same doors and hardware for new kitchen cabinet too.

A refaced kitchen receives the same products from the same companies including knobs, handles and drawer track ..

Overall, Halifax Kitchen Refacing ends up rating the kitchen cabinet refacing service in both Dartmouth and Halifax Nova Scotia as a service, product with better options out there. Saving time, energy and helping our environment. It also wants to emphasize that the conclusion was arrived at fairly, unbiased and with the consumer in mind.

Kitchen Refacers’s complete and unbiased write up and review Halifax, Dartmouth kitchen Refacing and Quartz Counter top Review can be found at Halifax Kitchen Refacing

Contact Info:
Name: Robert Stack
Email: Send Email
Organization: Kitchen Refacers
Address: 47 Lylewood Drive, Middle Sackville, Nova Scotia B4E 3B1, Canada
Phone: +1-902-448-2108
Website: https://www.kitchenrefacers.ca/cabinet-refacing-halifax

Source: PressCable

Release ID: 485342

Global Epoxy Resins Industry 2019-2023 Market Size, Share, Growth, Top 16 Key Players, Application, Trends, Demand and Forecast Research

The report scrutinizes the market by an exhaustive analysis on Global Epoxy Resins Market 2019 dynamics, market size, growth, shares, applications, current trends, demand, suppliers, challenges, forecasts, competition analysis, and top key players involved.

February 25, 2019 /MarketersMedia/

The worldwide market for Epoxy Resins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.

The Epoxy Resins Industry report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Epoxy Resins industry analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Get Sample Copy of this Report at – https://www.orianresearch.com/request-sample/670076 .

This report focuses on the Epoxy Resins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Asia Pacific is estimated to emerge as the largest as well as the fastest growing region over the forecast period. The growth in this region can be attributed to increasing demand for these resins in paints & coatings and composites.

Global Epoxy Resins Industry is spread across 145 pages, profiling 16 companies and supported with tables and figures.
Inquire more or share questions if any before the purchase on this report @ https://www.orianresearch.com/enquiry-before-buying/670076 .

The Manufacturers Analyzed in Global Epoxy Resins Market are – 3M (US), Adhesives Technology (US), Aditya Birla Chemicals (Thailand), Air Products and Chemicals (US), Alchemie. (UK), Asahi Kaseioration (Japan), Ashland (US), Atul (India), BASF SE (Germany), Chang Chun Plastics, Ciech (Poland), Cytec Solvay Group (US), DICoration (Japan), Emerald CVC Thermoset Specialties (US), Epic Resins (US), Hexion and Others.

Market Segment by Regions, regional analysis covers
• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
• Pure Epoxy Resin Adhesive
• Modified Epoxy Resin Adhesive

Market Segment by Applications, can be divided into
• Coating
• Electronic
• Building
• Material
• Other

Order a Copy of this Report @ https://www.orianresearch.com/checkout/670076 .

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Epoxy Resins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Epoxy Resins, with price, sales, revenue and global market share of Epoxy Resins in 2017 and 2018.
Chapter 3, the Epoxy Resins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Epoxy Resins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Epoxy Resins market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Epoxy Resins sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents:
1 Epoxy Resins Market Overview
2 Manufacturers Profiles
3 Global Epoxy Resins Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
4 Global Epoxy Resins Market Analysis by Regions
5 North America Epoxy Resins Revenue by Countries
6 Europe Epoxy Resins Revenue by Countries
7 Asia-Pacific Epoxy Resins Revenue by Countries
8 South America Epoxy Resins Revenue by Countries
9 Middle East and Africa Revenue Epoxy Resins by Countries
10 Global Epoxy Resins Market Segment by Type
11 Global Epoxy Resins Market Segment by Application
12 Global Epoxy Resins Market Size Forecast (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source

About Us
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world’s most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicated research offerings do not meet the specific requirements of our esteemed clients.

Contact Info:
Name: Ruwin Mendez
Email: Send Email
Organization: Orian Research
Website: https://www.orianresearch.com/report/global-epoxy-resins-market-2018-by-manufacturers-regions-type-and-application-forecast-to-2023/670076

Source URL: https://marketersmedia.com/global-epoxy-resins-industry-2019-2023-market-size-share-growth-top-16-key-players-application-trends-demand-and-forecast-research/485576

Source: MarketersMedia

Release ID: 485576

Physiological Saline Industry 2019-2024 Global Market Share, Growth, Future Scope, Demands, Key Players and Forecast Research

Physiological Saline Industry 2019 Global Market Research Report provides Market Overview and analysis about Manufacturing Cost Structure, Revenue, Gross Margin, Consumption, Major Manufacturers, Share, Distributors with Development Trends and Global Forecasts 2024.

February 25, 2019 /MarketersMedia/

The worldwide market for Physiological Saline is expected to grow at a CAGR of roughly 4.0% over the next five years, will reach 3350 million US$ in 2024, from 2750 million US$ in 2019, according to a new Study.

Physiological Saline is a mixture of sodium chloride in water and has a number of uses in medicine. Applied to the affected area it is used to clean wounds, help remove contact lenses, and help with dry eyes. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.

Get Sample Copy of this Report@ https://www.orianresearch.com/request-sample/804770

Global Physiological Saline Market competition by top manufacturers, with Production, Price, Revenue (value) and Market share for each manufacturer including:
• Baxter
• Hospira (Pfizer)
• Fresenius Kabi
• BBraun
• Otsuka
• Kelun Group
• …..

Key segments covered in this report: Geography segment, end use/application segment, and competitor segment. The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc. For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

Global Physiological Saline Industry 2019 Market Research Report is spread across 119 pages and provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector.

Inquire more or share questions if any before the purchase on this report@ https://www.orianresearch.com/enquiry-before-buying/804770

This report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers. Second on basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Physiological Saline, revenue and market share, for key manufacturers.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The study objectives of this report are:
• To analyze and study the global Physiological Saline sales, value, status (2013-2017) and forecast (2019-2024).
• Focuses on the key Physiological Saline manufacturers, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

Order a Copy of this Report@ https://www.orianresearch.com/checkout/804770

The main contents of the report including:
1 Market Overview
2 Manufacturers Profiles
3 Global Physiological Saline Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
4 Global Physiological Saline Market Analysis by Regions
5 North America Physiological Saline by Countries
6 Europe Physiological Saline by Countries
7 Asia-Pacific Physiological Saline by Countries
8 South America Physiological Saline by Countries
9 Middle East and Africa Physiological Saline by Countries
10 Global Physiological Saline Market Segment by Type
11 Global Physiological Saline Market Segment by Application
12 Physiological Saline Market Forecast (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix.
Research Methodology
Data Source

About Us
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world’s most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Info:
Name: Ruwin Mendez
Email: Send Email
Organization: Orian Research
Website: https://www.orianresearch.com/report/physiological-saline/804770

Source URL: https://marketersmedia.com/physiological-saline-industry-2019-2024-global-market-share-growth-future-scope-demands-key-players-and-forecast-research/485578

Source: MarketersMedia

Release ID: 485578

Lightweight Jackets Market 2019 Global Industry Sales, Supply, Demand and Consumption and Forecast to 2024

Wiseguyreports.Com Added New Market Research Report On -“Lightweight Jackets Market 2019 Top Key Players, Segmentation, Industry Analysis and Demand Forecast to 2024 ”.

Pune, India – February 25, 2019 /MarketersMedia/

Global Lightweight Jackets Market

WiseGuyRerports.com Presents “Global Lightweight Jackets Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024” New Document to its Studies Database. The Report Contain 135 Pages With Detailed Analysis.

Description

Lightweight jackets are a kind of jacks that are usually relative light and worn in the milder months. There are more and more functional lightweight jackets that are waterproof and windproof breathable. They are worn by men, women, boys, girls.

Scope of the Report: 
The Lightweight Jackets industry concentration is not high; there are numerous brands in the world, and high-end products mainly from U.S. and Western European. 

Global giant manufactures mainly distributed in U.S. and E.U, but their products are usually produced in China, India and other underdeveloped countries. China take a market share of 46.4% in 2016, followed by India with a proportion of 17.2%. 

This industry is affected by the economy and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to rising environment standards, especially in underdevelopment regions that have a large population and fast economic growth, the need of Lightweight Jackets will increase.

Get sample Report @ https://www.wiseguyreports.com/sample-request/3744863-global-lightweight-jackets-market-2019-by-manufacturers-regions

The worldwide market for Lightweight Jackets is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 153000 million US$ in 2024, from 108100 million US$ in 2019, according to a new GIR (Global Info Research) study. 

This report focuses on the Lightweight Jackets in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers 
NIKE 
Adidas 
Zara 
H&M 
Gap 
Uniqlo 
The North Face 
Burberry 
LOUIS VUITTON 
Esprit Holdings 
Columbia 
Meters/bonwe 
Semir 
Giorgio Armani 
Bestseller 
Forever 21 
ANTA 
Ralph Lauren Corporation 
Hanesbrands 
Li-ning 
PUMA 
Chanel 
Prada 
BOSS 
Dolce&Gabbana 
Patagonia 
Topman 
Canada Goose 
Moncler 
Helly Hansen 
Iconix Brand Group 
Free Country 
Alfred Dunner 
BISOU BISOU 
Barbour and Sons 
Asics 
Mizuno 
Under Armour

Market Segment by Regions, regional analysis covers 
North America (United States, Canada and Mexico) 
Europe (Germany, France, UK, Russia and Italy) 
Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
South America (Brazil, Argentina, Colombia etc.) 
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers 
Ordinary Type 
Functional Type

Market Segment by Applications, can be divided into 
Men 
Women 
Kids

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3744863-global-lightweight-jackets-market-2019-by-manufacturers-regions

 

Table of Contents -Major Key Points

1 Market Overview 
1.1 Lightweight Jackets Introduction 
1.2 Market Analysis by Type 
1.2.1 Ordinary Type 
1.2.2 Functional Type 
1.3 Market Analysis by Applications 
1.3.1 Men 
1.3.2 Women 
1.3.3 Kids 
1.4 Market Analysis by Regions 
1.4.1 North America (United States, Canada and Mexico) 
1.4.1.1 United States Market States and Outlook (2014-2024) 
1.4.1.2 Canada Market States and Outlook (2014-2024) 
1.4.1.3 Mexico Market States and Outlook (2014-2024) 
1.4.2 Europe (Germany, France, UK, Russia and Italy) 
1.4.2.1 Germany Market States and Outlook (2014-2024) 
1.4.2.2 France Market States and Outlook (2014-2024) 
1.4.2.3 UK Market States and Outlook (2014-2024) 
1.4.2.4 Russia Market States and Outlook (2014-2024) 
1.4.2.5 Italy Market States and Outlook (2014-2024) 
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
1.4.3.1 China Market States and Outlook (2014-2024) 
1.4.3.2 Japan Market States and Outlook (2014-2024) 
1.4.3.3 Korea Market States and Outlook (2014-2024) 
1.4.3.4 India Market States and Outlook (2014-2024) 
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 
1.4.4 South America, Middle East and Africa 
1.4.4.1 Brazil Market States and Outlook (2014-2024) 
1.4.4.2 Egypt Market States and Outlook (2014-2024) 
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 
1.4.4.4 South Africa Market States and Outlook (2014-2024) 
1.4.4.5 Turkey Market States and Outlook (2014-2024) 
1.5 Market Dynamics 
1.5.1 Market Opportunities 
1.5.2 Market Risk 
1.5.3 Market Driving Force 

2 Manufacturers Profiles 
2.1 NIKE 
2.1.1 Business Overview 
2.1.2 Lightweight Jackets Type and Applications 
2.1.2.1 Product A 
2.1.2.2 Product B 
2.1.3 NIKE Lightweight Jackets Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.2 Adidas 
2.2.1 Business Overview 
2.2.2 Lightweight Jackets Type and Applications 
2.2.2.1 Product A 
2.2.2.2 Product B 
2.2.3 Adidas Lightweight Jackets Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.3 Zara 
2.3.1 Business Overview 
2.3.2 Lightweight Jackets Type and Applications 
2.3.2.1 Product A 
2.3.2.2 Product B 
2.3.3 Zara Lightweight Jackets Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.4 H&M 
2.4.1 Business Overview 
2.4.2 Lightweight Jackets Type and Applications 
2.4.2.1 Product A 
2.4.2.2 Product B 
2.4.3 H&M Lightweight Jackets Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.5 Gap 
2.5.1 Business Overview 
2.5.2 Lightweight Jackets Type and Applications 
2.5.2.1 Product A 
2.5.2.2 Product B 
2.5.3 Gap Lightweight Jackets Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.6 Uniqlo 
2.6.1 Business Overview 
2.6.2 Lightweight Jackets Type and Applications 
2.6.2.1 Product A 
2.6.2.2 Product B 
2.6.3 Uniqlo Lightweight Jackets Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 

……..CONTINUED

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseguyReports
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +44 208 133 9349
Website: https://www.wiseguyreports.com/sample-request/2306360-global-spirits-industry-market-research-report

Source URL: https://marketersmedia.com/lightweight-jackets-market-2019-global-industry-sales-supply-demand-and-consumption-and-forecast-to-2024/485582

Source: MarketersMedia

Release ID: 485582